Alzeca Biosciences' Series A Round

Alzeca Biosciences raised a round of funding on August 17, 2017.

Alzeca Biosciences develops imaging compounds to diagnose Alzheimer's disease at the earliest stages. Early detection of Alzheimer's is critical as disease pathology begins to accumulate 10+ years pri…

Articles about Alzeca Biosciences' Series A Round: